The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
NCT04917796 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 255
Last updated 2026-01-30
Summary
This study is a randomized controlled trial of electroacupuncture (referred to as EA) versus sham acupuncture (referred to as EA) as effective treatments for Chemotherapy-Induced Peripheral Neuropathy (CIPN) pain in cancer survivors.
Conditions
- Chemotherapy-induced Peripheral Neuropathy
- Nerve Pain
- Neuropathy
- Neuropathy, Painful
- Pain
- CIPN - Chemotherapy-Induced Peripheral Neuropathy
Interventions
- OTHER
-
Electroacupuncture
Real and sham acupuncture will be delivered by experienced licensed acupuncturists. The intervention includes 10 treatments of acupuncture over 8 weeks (i.e., twice per week for two weeks, then one treatment per week for six weeks).
- OTHER
-
Sham Acupuncture
Real and sham acupuncture will be delivered by experienced licensed acupuncturists. The intervention includes 10 treatments of acupuncture over 8 weeks (i.e., twice per week for two weeks, then one treatment per week for six weeks).
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
collaborator OTHER - lead OTHER
Principal Investigators
-
Ting Bao, MD · Dana-Farber Cancer Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-21
- Primary Completion
- 2026-04-24
- Completion
- 2026-04-24
Countries
- United States
Study Locations
More Related Trials
-
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
NCT06121232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Ear Acupuncture for Neuropathic Pain
NCT05052645 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
NCT05935956 ·Status: COMPLETED
-
Evaluation of Effectiveness of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy for Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT07304401 ·Status: RECRUITING
-
Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device
NCT07061769 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer
NCT00281853 ·Status: COMPLETED
-
SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)
NCT05435742 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy
NCT01564069 ·Status: COMPLETED
-
Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs
NCT01208545 ·Status: UNKNOWN
-
Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain
NCT04239976 ·Status: COMPLETED ·Phase: NA
-
Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy
NCT00952848 ·Status: COMPLETED ·Phase: PHASE2
-
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
NCT00489411 ·Status: COMPLETED ·Phase: PHASE3
-
Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
NCT00068445 ·Status: COMPLETED ·Phase: PHASE3
-
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
NCT04560673 ·Status: RECRUITING ·Phase: PHASE2
-
Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies
NCT03156595 ·Status: UNKNOWN ·Phase: NA
-
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
NCT01196442 ·Status: COMPLETED ·Phase: NA
-
ACD440 Gel in Peripheral Neuropathic Pain
NCT05416931 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of TRP Channels in CIPN
NCT04415892 ·Status: RECRUITING ·Phase: NA
-
MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy
NCT01290224 ·Status: COMPLETED ·Phase: PHASE2
-
Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
NCT00058357 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study
NCT06744816 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)
NCT01278004 ·Status: COMPLETED ·Phase: PHASE2
-
MC5-A Scrambler Therapy or TENS Therapy in Treating Patients With Chemotherapy-Induced Peripheral Neuropathy
NCT02722434 ·Status: COMPLETED ·Phase: NA
-
Peripheral Blood Biomarkers Associated With CIPN
NCT02661399 ·Status: COMPLETED
-
Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy
NCT05840562 ·Status: RECRUITING ·Phase: PHASE3